logo
Plus   Neg
Share
Email

Roche Launches New Diagnostic Test For Breast And Gastric Cancer Patients

Roche (RHHBY) said it launched Ventana HER2 Dual ISH DNA Probe Cocktail assay, a new diagnostic test, to detect the HER2 biomarker in breast and gastric cancers.

HER2 or human epidermal growth factor receptor 2 is an important biomarker found in breast and gastric cancers. Its detection and inhibition can help to more effectively manage the aggressive cancers, the company said in a statement.

The new diagnostic test is designed to be completed within the same day, and the results can be read using light microscopy, eliminating the need for a specialized fluorescence microscope.

The company is currently launching the assay in Europe, the Middle East and Africa, as well as Latin America and Asia Pacific.

Roche is also planning to seek approval for the diagnostic test in the U.S.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
A survey has shown that while a majority of Americans want to buy a car that contributes substantially to the U.S. economy amid rising trade tensions, most of the "American-made" cars are actually produced by foreign automakers. According to Cars.com's 2019 American-Made Index, the most 'American-made' vehicle in 2019 is the Jeep Cherokee. Streaming giant Netflix Inc. (NFXL) is set to lose the right to stream "The Office," one of the most popular TV show on the service. NBC Universal announced it is taking back the popular TV show for its own streaming platform, beginning January 2021. "We're sad that NBC has decided to take The... Chinese smartphone maker Xiaomi has announced that its recently launched Mi Band 4 crossed 1 million units sales in just eight days. Xiaomi's Director of Product Management Donovan Sung tweeted this news as he thanked Mi fans for the achievement. "Sharing some great news with our global Mi Fans....
Follow RTT